Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the ...
BOSTON--(BUSINESS WIRE)--Jun 11, 2026-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the clinical benefits of CASGEVY ® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell …